Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Increased to Strong-Buy at StockNews.com

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday. Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price objective on shares of Aurinia Pharmaceuticals in a research […]

Leave a Reply

Your email address will not be published.

Previous post Bruins’ skid continues in 4-1 loss to Lightning
Next post Wishbone Gold (LON:WSBN) Stock Price Down 4.2% – Should You Sell?